It is important to remember that every drug available in pharmacies has been evaluated in clinical trials.
Study title: A multicentre, double-blind, randomized, placebo-controlled study comparing the efficacy and safety of NCT03535194 in patients with moderate to severe plaque psoriasis.
Therapeutic area: dermatology, psoriasis
Sponsor Name: Eli Lilly and Company
Test start date: June 26, 2018
End date: December 11, 2020
Status: Open recruitment
Other Clinical Trials
Check what tests we are currently conducting in our facility.